Wall Street analysts predict that Halyard Health Inc (NYSE:HYH) will report $0.49 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Halyard Health’s earnings, with the highest EPS estimate coming in at $0.51 and the lowest estimate coming in at $0.47. Halyard Health reported earnings per share of $0.50 in the same quarter last year, which suggests a negative year-over-year growth rate of 2%. The company is expected to announce its next quarterly earnings report on Monday, February 26th.
According to Zacks, analysts expect that Halyard Health will report full-year earnings of $2.08 per share for the current year, with EPS estimates ranging from $2.06 to $2.09. For the next financial year, analysts expect that the company will post earnings of $2.14 per share, with EPS estimates ranging from $2.01 to $2.27. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Halyard Health.
Halyard Health (NYSE:HYH) last released its quarterly earnings data on Wednesday, November 1st. The medical instruments supplier reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.47 by $0.13. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The firm had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. During the same quarter in the prior year, the company posted $0.48 earnings per share. The firm’s revenue was up 1.0% on a year-over-year basis.
Hedge funds and other institutional investors have recently modified their holdings of the company. Riverhead Capital Management LLC boosted its stake in shares of Halyard Health by 88.1% during the 2nd quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock worth $126,000 after acquiring an additional 1,497 shares during the period. Jarislowsky Fraser Ltd bought a new position in shares of Halyard Health during the 3rd quarter worth approximately $200,000. Quotient Investors LLC bought a new position in shares of Halyard Health during the 3rd quarter worth approximately $203,000. Jane Street Group LLC bought a new position in shares of Halyard Health during the 3rd quarter worth approximately $211,000. Finally, Victory Capital Management Inc. boosted its stake in shares of Halyard Health by 17.7% during the 2nd quarter. Victory Capital Management Inc. now owns 4,732 shares of the medical instruments supplier’s stock worth $186,000 after acquiring an additional 711 shares during the period. Institutional investors own 89.70% of the company’s stock.
Shares of Halyard Health (HYH) traded down $0.47 during trading on Monday, reaching $47.83. The company’s stock had a trading volume of 565,566 shares, compared to its average volume of 270,081. The company has a market capitalization of $2,260.00, a PE ratio of 40.19, a P/E/G ratio of 2.56 and a beta of 1.76. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49. Halyard Health has a 52-week low of $35.24 and a 52-week high of $50.99.
WARNING: “Halyard Health Inc (HYH) Expected to Announce Earnings of $0.49 Per Share” was originally reported by BBNS and is the sole property of of BBNS. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://baseballnewssource.com/markets/halyard-health-inc-hyh-expected-to-announce-earnings-of-0-49-per-share/1845437.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with our FREE daily email newsletter.